Odonate Therapeutics, Inc. (ODT)
Price:
1.12 USD
( - -0.05 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Regeneron Pharmaceuticals, Inc.
VALUE SCORE:
6
2nd position
Genmab A/S
VALUE SCORE:
11
The best
Agios Pharmaceuticals, Inc.
VALUE SCORE:
12
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.
NEWS
Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT
accessnewswire.com
2025-01-21 08:00:00FORT LAUDERDALE, FL / ACCESS Newswire / January 21, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its wholly owned Canadian subsidiary, Nora Pharma Inc., has launched two new generic prescription drugs. The newly launched drugs are Olanzapine and Olanzapine ODT.
MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD)
businesswire.com
2024-12-05 07:00:00NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that MM120 ODT, a pharmaceutically optimized form of lysergide D-tartrate (LSD), has been granted an Innovation Passport for the potential treatment of GAD under ILAP by the U.K. Medicines and Healthcare products Regulatory Agency (MHRA). The Innovation Passport is the.
Odonate Therapeutics Stock (ODT): Why The Price Plummeted Today
pulse2.com
2022-01-07 13:49:39The stock price of Odonate Therapeutics Inc (NASDAQ: ODT) fell by over 17% during intraday trading today. This is why it happened.
SHAREHOLDER ALERT: Odonate Therapeutics, Inc. (ODT) Officers and Directors Under Investigation for Possible False Statements to Investors
prnewswire.com
2021-08-13 09:00:00SAN FRANCISCO, Aug. 13, 2021 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of Odonate Therapeutics, Inc. (NASDAQ: ODT) relating to possible false statements to investors regarding its only product, tesetaxel, a drug the company was formerly developing for the treatment of breast cancer. A securities class action in the U.S. District Court for the Southern District of California recently survived a motion to dismiss allegations that between December 7, 2017 and March 19, 2021, Odonate and its CEO, CFO, and COO made false and misleading statements about the safety of tesetaxel, which was then undergoing a Phase 3 clinical trial for the treatment of breast cancer.
The Law Offices of Frank R. Cruz Announces Investigation of Odonate Therapeutics, Inc. (ODT) on Behalf of Investors
businesswire.com
2021-08-06 19:17:00LOS ANGELES--(BUSINESS WIRE)---- $ODT #investors--The Law Offices of Frank R. Cruz Announces Investigation of Odonate Therapeutics, Inc. (ODT) on Behalf of Investors
Why Odonate Therapeutics, Opthea, ALX Oncology, Advaxis and Provention Bio Are Moving Today
benzinga.com
2021-07-06 10:16:08Odonate Therapeutics, Inc. (NASDAQ: ODT), Opthea Limited (NASDAQ: OPT), ALX Oncology Holdings Inc. (NASDAQ: ALXO), Provention Bio, Inc. (NASDAQ: PRVB) and Advaxis, Inc. (NASDAQ: ADXS) are among the biggest biopharma movers Tuesday. Odonate Gains On Institutional Stake: Shares of Odonate, a biopharma which recently announced discontinuation of development of an oral chemotherapy candidate named tesetaxel, are seeing renewed buying following disclosure of institutional stake.
ODT Stock Price Increases Over 20% Pre-Market: Details
pulse2.com
2021-07-06 07:42:20The stock price of Odonate Therapeutics Inc (NASDAQ: ODT) increased by over 20% pre-market. These are some details you should know.
7 Penny Stocks For Your Watch List This Week If You Like Biotech In July
pennystocks.com
2021-07-05 12:29:05Looking for biotech penny stocks to watch right now? Here are 7 for your list this week.
3 Net Current Asset Value Stock Picks
gurufocus.com
2021-05-11 12:59:59There are some investors who buy U.S.-listed stocks that are trading below their liquidation value because they believe they can gain from these kinds of investments after the market has reappraised the share prices to near or above the liquidation value.
Odonate Therapeutics (ODT) Enters Oversold Territory
zacks.com
2021-05-06 09:01:57Odonate Therapeutics (ODT) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
Odonate Therapeutics: Lessons Learned
seekingalpha.com
2021-04-27 05:43:16Odonate shut down its Tesetaxel program - and the company itself - without any warning.
Odonate Therapeutics (ODT) is Oversold: Can It Recover?
zacks.com
2021-04-09 08:19:21Odonate Therapeutics (ODT) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Odonate Therapeutics Stock Price Increased 12.14%: Why It Happened
pulse2.com
2021-04-07 22:12:00The stock price of Odonate Therapeutics Inc (NASDAQ: ODT) increased by 12.14% unexpectedly. These are some detail about the company you should know about.
Do Options Traders Know Something About Odonate Therapeutics (ODT) Stock We Don't?
zacks.com
2021-03-24 09:12:09Investors need to pay close attention to Odonate Therapeutics (ODT) stock based on the movements in the options market lately.
ODT Stock Price Fell 79.19%: Why It Happened
pulse2.com
2021-03-23 07:41:56The stock price of Odonate Therapeutics Inc (NASDAQ: ODT) fell by 79.19% yesterday. This is why it happened.
Odonate Therapeutics stock plummets toward record low after plan to 'wind down' operations
marketwatch.com
2021-03-22 13:36:59Shares of Odonate Therapeutics Inc. plummeted 79.0% in active afternoon trading Monday, after the pharmaceutical company said it will wind down operations following disappointing data from its cancer treatment. The company said it determined, following feedback from the Food and Drug Administration in a pre-New Drug Application (pre-NDA) meeting, that tesetaxel, an orally administered chemotherapy agent, is unlikely to receive FDA approval.
No data to display
Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT
accessnewswire.com
2025-01-21 08:00:00FORT LAUDERDALE, FL / ACCESS Newswire / January 21, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its wholly owned Canadian subsidiary, Nora Pharma Inc., has launched two new generic prescription drugs. The newly launched drugs are Olanzapine and Olanzapine ODT.
MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD)
businesswire.com
2024-12-05 07:00:00NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that MM120 ODT, a pharmaceutically optimized form of lysergide D-tartrate (LSD), has been granted an Innovation Passport for the potential treatment of GAD under ILAP by the U.K. Medicines and Healthcare products Regulatory Agency (MHRA). The Innovation Passport is the.
Odonate Therapeutics Stock (ODT): Why The Price Plummeted Today
pulse2.com
2022-01-07 13:49:39The stock price of Odonate Therapeutics Inc (NASDAQ: ODT) fell by over 17% during intraday trading today. This is why it happened.
SHAREHOLDER ALERT: Odonate Therapeutics, Inc. (ODT) Officers and Directors Under Investigation for Possible False Statements to Investors
prnewswire.com
2021-08-13 09:00:00SAN FRANCISCO, Aug. 13, 2021 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of Odonate Therapeutics, Inc. (NASDAQ: ODT) relating to possible false statements to investors regarding its only product, tesetaxel, a drug the company was formerly developing for the treatment of breast cancer. A securities class action in the U.S. District Court for the Southern District of California recently survived a motion to dismiss allegations that between December 7, 2017 and March 19, 2021, Odonate and its CEO, CFO, and COO made false and misleading statements about the safety of tesetaxel, which was then undergoing a Phase 3 clinical trial for the treatment of breast cancer.
The Law Offices of Frank R. Cruz Announces Investigation of Odonate Therapeutics, Inc. (ODT) on Behalf of Investors
businesswire.com
2021-08-06 19:17:00LOS ANGELES--(BUSINESS WIRE)---- $ODT #investors--The Law Offices of Frank R. Cruz Announces Investigation of Odonate Therapeutics, Inc. (ODT) on Behalf of Investors
Why Odonate Therapeutics, Opthea, ALX Oncology, Advaxis and Provention Bio Are Moving Today
benzinga.com
2021-07-06 10:16:08Odonate Therapeutics, Inc. (NASDAQ: ODT), Opthea Limited (NASDAQ: OPT), ALX Oncology Holdings Inc. (NASDAQ: ALXO), Provention Bio, Inc. (NASDAQ: PRVB) and Advaxis, Inc. (NASDAQ: ADXS) are among the biggest biopharma movers Tuesday. Odonate Gains On Institutional Stake: Shares of Odonate, a biopharma which recently announced discontinuation of development of an oral chemotherapy candidate named tesetaxel, are seeing renewed buying following disclosure of institutional stake.
ODT Stock Price Increases Over 20% Pre-Market: Details
pulse2.com
2021-07-06 07:42:20The stock price of Odonate Therapeutics Inc (NASDAQ: ODT) increased by over 20% pre-market. These are some details you should know.
7 Penny Stocks For Your Watch List This Week If You Like Biotech In July
pennystocks.com
2021-07-05 12:29:05Looking for biotech penny stocks to watch right now? Here are 7 for your list this week.
3 Net Current Asset Value Stock Picks
gurufocus.com
2021-05-11 12:59:59There are some investors who buy U.S.-listed stocks that are trading below their liquidation value because they believe they can gain from these kinds of investments after the market has reappraised the share prices to near or above the liquidation value.
Odonate Therapeutics (ODT) Enters Oversold Territory
zacks.com
2021-05-06 09:01:57Odonate Therapeutics (ODT) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
Odonate Therapeutics: Lessons Learned
seekingalpha.com
2021-04-27 05:43:16Odonate shut down its Tesetaxel program - and the company itself - without any warning.
Odonate Therapeutics (ODT) is Oversold: Can It Recover?
zacks.com
2021-04-09 08:19:21Odonate Therapeutics (ODT) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Odonate Therapeutics Stock Price Increased 12.14%: Why It Happened
pulse2.com
2021-04-07 22:12:00The stock price of Odonate Therapeutics Inc (NASDAQ: ODT) increased by 12.14% unexpectedly. These are some detail about the company you should know about.
Do Options Traders Know Something About Odonate Therapeutics (ODT) Stock We Don't?
zacks.com
2021-03-24 09:12:09Investors need to pay close attention to Odonate Therapeutics (ODT) stock based on the movements in the options market lately.
ODT Stock Price Fell 79.19%: Why It Happened
pulse2.com
2021-03-23 07:41:56The stock price of Odonate Therapeutics Inc (NASDAQ: ODT) fell by 79.19% yesterday. This is why it happened.
Odonate Therapeutics stock plummets toward record low after plan to 'wind down' operations
marketwatch.com
2021-03-22 13:36:59Shares of Odonate Therapeutics Inc. plummeted 79.0% in active afternoon trading Monday, after the pharmaceutical company said it will wind down operations following disappointing data from its cancer treatment. The company said it determined, following feedback from the Food and Drug Administration in a pre-New Drug Application (pre-NDA) meeting, that tesetaxel, an orally administered chemotherapy agent, is unlikely to receive FDA approval.